Related references
Note: Only part of the references are listed.Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
Liyang Cui et al.
NATURE BIOTECHNOLOGY (2021)
In situ triggering antitumor efficacy of alcohol-abuse drug disulfiram through Cu-based metal-organic framework nanoparticles
Lin Hou et al.
ACTA PHARMACEUTICA SINICA B (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow
Weiwei Liu et al.
ACS NANO (2021)
Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death
Xuejia Kang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
A PDA-DTC/Cu-MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment
Xiaochun Hu et al.
CHEMICAL COMMUNICATIONS (2021)
Three birds with one stone: A ferric pyrophosphate based nanoagent for synergetic NIR-triggered photo/chemodynamic therapy with glutathione depletion
Yanjuan Huang et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Tumor-targeted supramolecular catalytic nanoreactor for synergistic chemo/chemodynamic therapy via oxidative stress amplification and cascaded Fenton reaction
Xiaoyu Xu et al.
CHEMICAL ENGINEERING JOURNAL (2020)
A light-triggered self-reinforced nanoagent for targeted chemo-photodynamic therapy of breast cancer bone metastases via ER stress and mitochondria mediated apoptotic pathways
Yanjuan Huang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
The combination of disulfiram and copper for cancer treatment
Hong Li et al.
DRUG DISCOVERY TODAY (2020)
Apoferritin as a Carrier of Cu(II) Diethyldithiocarbamate and Biomedical Application for Glutathione-Responsive Combination Chemotherapy
Xiao Li et al.
ACS APPLIED BIO MATERIALS (2020)
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition
Wencheng Wu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy
Muhammad Asim Farooq et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Metal-organic framework nanosheets with flower-like structure as probes for H2S detection and in situ singlet-oxygen production
Pinghua Ling et al.
CHEMICAL COMMUNICATIONS (2019)
A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy
Qingqing Pan et al.
CHEMICAL COMMUNICATIONS (2019)
Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor
Zeqian Huang et al.
THERANOSTICS (2019)
Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Wu Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer
Mohammad Najlah et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Hyaluronic acid for anticancer drug and nucleic acid delivery
Franco Dosio et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
A second look: Efforts to repurpose old drugs against Zika cast a wide net
Ellie Kincaid
NATURE MEDICINE (2016)
Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
F. R. Kona et al.
CURRENT CANCER DRUG TARGETS (2011)
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo et al.
CANCER LETTERS (2010)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
DZ Cen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Share Paper
